These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38547667)

  • 1. Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome).
    Wang B; Ren Q; Cui X; Shan W; Guo X; Wang X; Wang J; Li Y; An G
    Stem Cell Res; 2024 Jun; 77():103400. PubMed ID: 38547667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.
    Guo F; Sun Y; Wang H; Wang H; Zhou J; Fan H; Su J; Gong T; Jiang C; Liang P
    Stem Cell Res; 2022 Jul; 62():102813. PubMed ID: 35569348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant.
    Zhao J; Wang L; Zhu K; Chen X; Qin F; Li X; Dong J; Tao H
    Stem Cell Res; 2022 Aug; 63():102836. PubMed ID: 35700634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant.
    Garg P; Oikonomopoulos A; Chen H; Li Y; Lam CK; Sallam K; Perez M; Lux RL; Sanguinetti MC; Wu JC
    J Am Coll Cardiol; 2018 Jul; 72(1):62-75. PubMed ID: 29957233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of SCN1B knock out induced pluripotent stem cell (iPSC) line (refractory epilepsy syndrome and Brugada syndrome related cell line).
    Shan W; An G; Ren Q; Wang Q
    Stem Cell Res; 2021 Oct; 56():102545. PubMed ID: 34583279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.
    Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
    Mura M; Mehta A; Ramachandra CJ; Zappatore R; Pisano F; Ciuffreda MC; Barbaccia V; Crotti L; Schwartz PJ; Shim W; Gnecchi M
    Int J Cardiol; 2017 Aug; 240():367-371. PubMed ID: 28433559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2.
    Wang T; Zhou Y; Zhou R; Huang W; Wang J; Li H; Lei M; Tan X; Zhang Y
    Stem Cell Res; 2021 Oct; 56():102509. PubMed ID: 34438161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
    Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
    Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
    O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
    Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
    Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome.
    Mesquita FCP; Arantes PC; Kasai-Brunswick TH; Araujo DS; Gubert F; Monnerat G; Silva Dos Santos D; Neiman G; Leitão IC; Barbosa RAQ; Coutinho JL; Vaz IM; Dos Santos MN; Borgonovo T; Cruz FES; Miriuka S; Medei EH; Campos de Carvalho AC; Carvalho AB
    Sci Rep; 2019 Dec; 9(1):19203. PubMed ID: 31844156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating a human induced pluripotent stem cell line (XACHi018-A) from a Timothy syndrome infant carrying heterozygous CACNA1C c.1216G>A (p.G406R) mutation.
    Jiang C; Huang W; Zhou Y; Wang J; Lei H; Niu Y; Zhou R; Zhang Y
    Stem Cell Res; 2024 Oct; 80():103513. PubMed ID: 39079396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
    Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
    Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line.
    Shan W; Yang X; Ren Q; Wang Q
    Stem Cell Res; 2021 Aug; 55():102452. PubMed ID: 34247112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome.
    Cai D; Zheng Z; Jin X; Fu Y; Cen L; Ye J; Song Y; Lian J
    J Cardiovasc Transl Res; 2023 Feb; 16(1):209-220. PubMed ID: 35976484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias.
    Brandão KO; van den Brink L; Miller DC; Grandela C; van Meer BJ; Mol MPH; de Korte T; Tertoolen LGJ; Mummery CL; Sala L; Verkerk AO; Davis RP
    Stem Cell Reports; 2020 Nov; 15(5):1127-1139. PubMed ID: 33176122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes.
    Park NK; Park SJ; Park YG; Moon SH; Woo J; Kim HJ; Kim SJ; Choi SW
    Hum Mol Genet; 2024 Jan; 33(2):110-121. PubMed ID: 37769355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.